Colgate-Palmolive Company $CL Shares Bought by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC increased its stake in Colgate-Palmolive Company (NYSE:CL) by 217.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 40,605 shares of the company’s stock after acquiring an additional 27,796 shares during the period. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Colgate-Palmolive were worth $3,246,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in CL. Brighton Jones LLC increased its position in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP lifted its holdings in shares of Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after buying an additional 20,062 shares during the period. Schnieders Capital Management LLC. lifted its holdings in shares of Colgate-Palmolive by 2.0% in the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after buying an additional 245 shares during the period. Vestmark Advisory Solutions Inc. bought a new position in Colgate-Palmolive during the second quarter valued at about $252,000. Finally, AE Wealth Management LLC boosted its stake in Colgate-Palmolive by 44.0% during the second quarter. AE Wealth Management LLC now owns 12,048 shares of the company’s stock valued at $1,095,000 after buying an additional 3,680 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Barclays lifted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. The Goldman Sachs Group reiterated a “buy” rating and issued a $100.00 target price on shares of Colgate-Palmolive in a report on Friday, February 20th. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a research note on Tuesday, December 9th. Finally, Morgan Stanley raised their target price on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $94.75.

Insider Activity

In related news, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. This represents a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 in the last quarter. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.6%

Shares of CL opened at $92.45 on Wednesday. The business’s 50-day moving average price is $89.50 and its 200 day moving average price is $83.13. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The stock has a market capitalization of $74.52 billion, a P/E ratio of 35.29, a P/E/G ratio of 4.17 and a beta of 0.28. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.